TuHURA BIOSCIENCES, INC./NV Earnings Per Share (Basic)
TuHURA BIOSCIENCES, INC./NV (HURA) reported Earnings Per Share (Basic) of -$0.14 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- TuHURA BIOSCIENCES, INC./NV earnings per share, basic for the quarter ending 2026-06-30 was -$0.14.
- TuHURA BIOSCIENCES, INC./NV earnings per share, basic for the quarter ending 2026-03-31 was -$0.13.
- TuHURA BIOSCIENCES, INC./NV earnings per share, basic for the quarter ending 2025-12-31 was -$0.13.
- TuHURA BIOSCIENCES, INC./NV earnings per share, basic for the quarter ending 2025-09-30 was -$0.14.
- TuHURA BIOSCIENCES, INC./NV earnings per share, basic for fiscal 2025 was -$0.63.
- TuHURA BIOSCIENCES, INC./NV earnings per share, basic for fiscal 2024 was -$1.21.
- TuHURA BIOSCIENCES, INC./NV earnings per share, basic for fiscal 2024 was -$0.32.
- TuHURA BIOSCIENCES, INC./NV earnings per share, basic for fiscal 2023 was -$2.47.
| Period end | Earnings Per Share, Basic 0 month | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.14 10-Q · filed 2026-08-14 | -$0.27 10-Q · filed 2026-08-14 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||||
| 2026-03-31 | -$0.13 10-Q · filed 2026-05-15 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.59 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||||
| 2025-12-31 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.47 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.63 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | -$0.14 10-Q · filed 2025-11-14 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.50 10-Q · filed 2025-11-14 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||||
| 2025-06-30 | -$0.21 10-Q · filed 2026-08-14 | -$0.36 10-Q · filed 2026-08-14 | -$0.53 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-08-14 | |||||
| 2025-03-31 | -$0.15 10-Q · filed 2026-05-15 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-05-15 | |||||
| 2024-12-31 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-03-31 | -$1.21 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | -$0.54 10-Q · filed 2025-11-14 | -$1.37 10-Q · filed 2024-11-14 | -$0.97 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$1.37 10-Q · filed 2025-11-14 | -$1.73 derived: net income ÷ weighted average shares · filed 2025-11-14 | ||||
| 2024-06-30 | -$0.43 10-Q · filed 2025-08-14 | -$0.83 10-Q · filed 2025-08-14 | -$1.16 derived: net income ÷ weighted average shares · filed 2025-08-14 | -$0.32 10-K · filed 2024-10-07 | |||||
| 2024-03-31 | -$0.40 10-Q · filed 2025-05-15 | -$0.05 10-Q · filed 2024-05-14 | -$0.71 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$0.37 10-Q · filed 2024-05-14 | -$2.70 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||||
| 2023-12-31 | -$0.24 10-Q · filed 2024-02-14 | -$1.37 10-Q · filed 2024-02-14 | -$3.70 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$2.47 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | -$63.92 10-Q · filed 2024-11-14 | -$1.83 10-Q · filed 2023-11-13 | -$7.44 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$8.54 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$10.42 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2023-06-30 | -$1.97 derived: net income ÷ weighted average shares · filed 2024-10-07 | -$3.92 derived: net income ÷ weighted average shares · filed 2024-10-07 | -$6.02 derived: net income ÷ weighted average shares · filed 2024-10-07 | -$9.27 10-K · filed 2024-10-07 | |||||
| 2023-03-31 | -$1.94 10-Q · filed 2024-05-14 | -$4.04 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$7.32 10-Q · filed 2024-05-14 | -$11.33 derived: net income ÷ weighted average shares · filed 2024-05-14 | |||||
| 2022-12-31 | -$2.10 10-Q · filed 2024-02-14 | -$5.42 10-Q · filed 2024-02-14 | -$9.53 derived: net income ÷ weighted average shares · filed 2024-02-14 | -$14.37 derived: net income ÷ weighted average shares · filed 2024-02-14 | |||||
| 2022-09-30 | -$3.39 10-Q · filed 2023-11-13 | -$0.07 10-Q · filed 2022-11-09 | -$7.64 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$12.76 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$18.53 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||||
| 2022-06-30 | -$4.33 derived: net income ÷ weighted average shares · filed 2023-09-18 | -$9.64 derived: net income ÷ weighted average shares · filed 2023-09-18 | -$15.59 derived: net income ÷ weighted average shares · filed 2023-09-18 | -$25.80 10-K · filed 2023-09-18 | -$0.52 10-K · filed 2022-09-27 | ||||
| 2022-03-31 | -$5.45 10-Q · filed 2023-05-11 | -$0.11 10-Q · filed 2022-05-13 | -$11.52 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$22.39 10-Q · filed 2023-05-11 | -$0.45 10-Q · filed 2022-05-13 | -$1.54 derived: net income ÷ weighted average shares · filed 2023-05-11 | |||
| 2021-12-31 | -$6.07 10-Q · filed 2023-02-14 | $0.12 10-Q · filed 2022-02-11 | -$17.30 10-Q · filed 2023-02-14 | $0.35 10-Q · filed 2022-02-11 | -$0.93 derived: net income ÷ weighted average shares · filed 2023-02-14 | -$1.14 derived: net income ÷ weighted average shares · filed 2023-02-14 | |||
| 2021-09-30 | -$0.25 10-Q · filed 2022-11-09 | $0.25 10-Q · filed 2021-11-15 | -$0.45 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.68 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$0.90 derived: net income ÷ weighted average shares · filed 2022-11-09 | ||||
| 2021-06-30 | -$0.21 derived: net income ÷ weighted average shares · filed 2022-09-27 | -$0.43 derived: net income ÷ weighted average shares · filed 2022-09-27 | -$0.65 derived: net income ÷ weighted average shares · filed 2022-09-27 | -$1.60 10-K · filed 2022-09-27 | |||||
| 2021-03-31 | -$0.23 10-Q · filed 2022-05-13 | $0.23 10-Q · filed 2021-05-13 | -$0.45 derived: net income ÷ weighted average shares · filed 2022-05-13 | -$1.47 10-Q · filed 2022-05-13 | $1.47 10-Q · filed 2021-05-13 | -$1.87 derived: net income ÷ weighted average shares · filed 2022-05-13 | |||
| 2020-12-31 | $0.22 10-Q · filed 2022-02-11 | -$1.34 10-Q · filed 2022-02-11 | $1.34 10-Q · filed 2021-02-12 | -$1.80 derived: net income ÷ weighted average shares · filed 2022-02-11 | -$2.09 derived: net income ÷ weighted average shares · filed 2022-02-11 | ||||
| 2020-09-30 | -$1.33 10-Q · filed 2021-11-15 | $1.33 10-Q · filed 2020-11-12 | -$1.86 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$2.14 derived: net income ÷ weighted average shares · filed 2021-11-15 | -$2.36 derived: net income ÷ weighted average shares · filed 2021-11-15 | ||||
| 2020-06-30 | -$0.34 derived: net income ÷ weighted average shares · filed 2021-09-28 | -$0.51 derived: net income ÷ weighted average shares · filed 2021-09-28 | -$0.66 derived: net income ÷ weighted average shares · filed 2021-09-28 | -$0.87 10-K · filed 2021-09-28 | $0.87 10-K · filed 2020-09-18 | ||||
| 2020-03-31 | $0.17 10-Q · filed 2021-05-13 | -$0.32 derived: net income ÷ weighted average shares · filed 2021-05-13 | $0.52 10-Q · filed 2021-05-13 | -$0.95 derived: net income ÷ weighted average shares · filed 2021-05-13 | |||||
| 2019-12-31 | $0.15 10-Q · filed 2021-02-12 | $0.35 10-Q · filed 2021-02-12 | -$0.81 derived: net income ÷ weighted average shares · filed 2021-02-12 | -$1.25 derived: net income ÷ weighted average shares · filed 2021-02-12 | |||||
| 2019-09-30 | $0.21 10-Q · filed 2020-11-12 | -$0.80 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$1.36 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$2.00 derived: net income ÷ weighted average shares · filed 2020-11-12 | |||||
| 2019-06-30 | -$0.87 derived: net income ÷ weighted average shares · filed 2020-09-18 | -$1.56 derived: net income ÷ weighted average shares · filed 2020-09-18 | -$2.31 derived: net income ÷ weighted average shares · filed 2020-09-18 | $3.16 10-K · filed 2020-09-18 | |||||
| 2019-03-31 | $0.67 10-Q · filed 2020-05-13 | -$1.42 derived: net income ÷ weighted average shares · filed 2020-05-13 | $2.27 10-Q · filed 2020-05-13 | $6.16 derived: net income ÷ weighted average shares · filed 2020-05-13 | |||||
| 2018-12-31 | $0.75 10-Q · filed 2020-02-13 | $0.08 10-Q · filed 2019-02-11 | $1.63 10-Q · filed 2020-02-13 | $0.16 10-Q · filed 2019-02-11 | $7.00 derived: net income ÷ weighted average shares · filed 2020-02-13 | $5.76 derived: net income ÷ weighted average shares · filed 2020-02-13 | |||
| 2018-09-30 | $0.88 10-Q · filed 2019-11-13 | $0.09 10-Q · filed 2018-11-13 | $7.93 derived: net income ÷ weighted average shares · filed 2019-11-13 | $6.64 derived: net income ÷ weighted average shares · filed 2019-11-13 | $1.63 derived: net income ÷ weighted average shares · filed 2019-11-13 | ||||
| 2018-06-30 | $8.83 derived: net income ÷ weighted average shares · filed 2019-09-09 | $7.54 derived: net income ÷ weighted average shares · filed 2019-09-09 | $1.55 derived: net income ÷ weighted average shares · filed 2019-09-09 | $5.42 10-K · filed 2019-09-09 | $0.54 10-K · filed 2018-09-24 | ||||
| 2018-03-31 | $1.31 10-Q · filed 2019-05-14 | $0.13 10-Q · filed 2018-05-15 | -$0.50 derived: net income ÷ weighted average shares · filed 2019-05-14 | $4.41 10-Q · filed 2019-05-14 | $0.44 10-Q · filed 2018-05-15 | -$4.36 derived: net income ÷ weighted average shares · filed 2019-06-03 | |||
| 2017-12-31 | $0.14 10-Q · filed 2019-02-11 | $0.31 10-Q · filed 2019-02-11 | -$3.09 derived: net income ÷ weighted average shares · filed 2019-06-03 | -$2.15 derived: net income ÷ weighted average shares · filed 2019-06-03 | |||||
| 2017-09-30 | $0.18 10-Q · filed 2018-11-13 | $0.76 derived: net income ÷ weighted average shares · filed 2019-06-03 | $8.62 derived: net income ÷ weighted average shares · filed 2019-06-03 | -$4.08 derived: net income ÷ weighted average shares · filed 2019-06-03 | |||||
| 2017-06-30 | $0.09 derived: net income ÷ weighted average shares · filed 2019-06-03 | $0.54 derived: net income ÷ weighted average shares · filed 2019-06-03 | $2.91 derived: net income ÷ weighted average shares · filed 2019-06-03 | $7.36 8-K · filed 2019-06-03 | $0.74 10-K · filed 2017-09-27 | ||||
| 2017-03-31 | $0.18 10-Q · filed 2018-05-15 | -$0.31 derived: net income ÷ weighted average shares · filed 2018-05-15 | $0.54 10-Q · filed 2018-05-15 | $0.24 derived: net income ÷ weighted average shares · filed 2018-05-15 | |||||
| 2016-12-31 | $0.13 10-Q · filed 2018-02-14 | $0.36 10-Q · filed 2018-02-14 | $0.43 derived: net income ÷ weighted average shares · filed 2018-02-14 | $0.53 derived: net income ÷ weighted average shares · filed 2018-02-14 | |||||
| 2016-09-30 | $0.23 10-Q · filed 2017-11-09 | $0.56 derived: net income ÷ weighted average shares · filed 2017-11-09 | $0.67 derived: net income ÷ weighted average shares · filed 2017-11-09 | $0.91 derived: net income ÷ weighted average shares · filed 2017-11-09 | |||||
| 2016-06-30 | $0.33 derived: net income ÷ weighted average shares · filed 2017-09-27 | $0.44 derived: net income ÷ weighted average shares · filed 2017-09-27 | $0.68 derived: net income ÷ weighted average shares · filed 2017-09-27 | $0.83 10-K · filed 2017-09-27 | $0.81 10-K · filed 2016-09-13 | ||||
| 2016-03-31 | $0.03 10-Q · filed 2016-05-12 | $0.34 derived: net income ÷ weighted average shares · filed 2017-05-12 | $0.12 10-Q · filed 2016-05-12 | ||||||
| 2015-12-31 | $0.06 10-Q · filed 2016-02-12 | $0.10 10-Q · filed 2016-02-12 | |||||||
| 2015-09-30 | $0.15 10-Q · filed 2016-11-10 | $0.04 10-Q · filed 2015-11-16 | |||||||
| 2015-06-30 | $0.46 10-K · filed 2016-09-13 | $0.13 10-K · filed 2015-09-03 | |||||||
| 2015-03-31 | $0.05 10-Q · filed 2016-05-12 | $0.04 10-Q · filed 2015-05-15 | $0.11 10-Q · filed 2016-05-12 | ||||||
| 2014-12-31 | $0.02 10-Q · filed 2016-02-12 | $0.03 10-Q · filed 2015-02-12 | $0.06 10-Q · filed 2016-02-12 | ||||||
| 2014-09-30 | $0.04 10-Q · filed 2015-11-16 | ||||||||
| 2014-06-30 | -$0.20 10-K · filed 2015-11-16 | -$0.10 10-K · filed 2015-09-03 | |||||||
| 2014-03-31 | $0.10 10-Q · filed 2015-05-15 | -$0.09 10-Q · filed 2015-05-15 | |||||||
| 2013-12-31 | $0.03 10-Q · filed 2015-02-12 | -$0.19 10-Q · filed 2015-02-12 | |||||||
| 2013-09-30 | -$0.22 10-Q · filed 2014-11-07 | $0.22 10-Q · filed 2013-11-08 | -$0.26 10-Q · filed 2013-11-08 | ||||||
| 2012-09-30 | -$0.03 10-Q · filed 2013-11-08 | -$0.15 10-Q · filed 2013-11-08 | |||||||
| 2012-06-30 | -$0.01 10-K/A · filed 2012-12-20 | ||||||||
| 2011-06-30 | $0.00 10-K/A · filed 2012-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |